Table 1.

Demographic Characteristics, Mental Health Diagnoses, Opioid Daily Dose, and Benzodiazepine Prescriptions Among Patients on Chronic Opioid Therapy in 2018 and 2019

20182019P
N387231
Age, mean (SD)60.60 (12.59)59.75 (11.57).404
Male gender, n (%)140 (36.2)72 (31.2).238
Race, n (%)    .053
 Black or African American154 (39.8)73 (31.6)
 White or Caucasian229 (59.2)152 (65.8)
 Other4 (1.0)6 (2.6)
Ethnicity, n (%)    .245
 Hispanic or Latino2 (0.5)4 (1.7)
 Not Hispanic or Latino384 (99.2)227 (98.3)
 Patient refused1 (0.3)0 (0.0)
Any psychiatric diagnosis, n (%)193 (49.9)213 (92.2)< .001
Depression, n (%)101 (26.1)154 (66.7)< .001
Anxiety, n (%)109 (28.2)140 (60.6)< .001
Bipolar, n (%)21 (5.4)20 (8.7).163
Adjustment, n (%)43 (11.1)70 (30.3)< .001
PTSD, n (%)6 (1.6)12 (5.2).018
Other, n (%)24 (6.2)39 (16.9)< .001
MME daily dose    .03
 ≥ 90 MME, n (%)31 (8.0)30 (13.0)
 50 to 89.9 MME, n (%)40 (10.3)33 (14.3)
 < 50 MME, n (%)316 (81.7)168 (72.7)
Benzodiazepine Rx n (%)121 (31.3)77 (33.3).657
  • MME, morphine milligram equivalent; SD, standard deviation; PTSD, post-traumatic stress disorder.